Logo
Home|Clinics & Hospitals|Departments or Services|Insurance Companies|Health News|Contact Us
HomeClinics & HospitalsDepartments or ServicesInsurance CompaniesHealth NewsContact Us

Search

Health News

Multivitamins 'waste of money,' say medical experts

Date: Dec-18-2013
"Enough is enough: stop wasting money on vitamin and mineral supplements," say medical experts in an editorial of a leading journal that has just published three new studies examining whether routine use of vitamin and mineral supplements brings health benefits.Writing in Annals of Internal Medicine, the editorial authors conclude that most supplements do not prevent chronic disease or death, some may even be harmful in well-nourished adults, and there is a large body of evidence to support this.

Study confirms fibroblast growth factor receptors as targets for pancreatic cancer treatment

Date: Dec-18-2013
Proteins called fibroblast growth factor receptors (FGFRs) have been implicated in the development of pancreatic cancer, which remains difficult to treat. Researchers at Roswell Park Cancer Institute (RPCI) have now confirmed that FGFRs can be used as treatment targets in preclinical studies, and have identified certain molecular characteristics that could be useful in developing personalized treatments for patients with pancreatic cancer. Study results have been published online first in the British Journal of Cancer.

Major imaging study uses Siemens MR technology to transform disease research

Date: Dec-18-2013
UK Biobank, a world-leading health research resource, is putting preparations in place for a study to help scientists gain a more detailed understanding of a wide range of diseases including dementia, cancer and heart, bone and brain disorders. Drawing on the MR imaging capabilities of a MAGNETOM® Aera and a MAGNETOM Skyra from Siemens Healthcare, it is expected to be the most detailed study of its kind ever undertaken. The MR systems will be used to obtain the crucial translational research images of participants' hearts and brains.

Pitt-led microbicide trials network awarded $70 million over seven years to develop, test HIV prevention products

Date: Dec-18-2013
With funding of $70 million to support its effort into 2021, the Microbicide Trials Network (MTN) will continue to develop and test products that aim to reduce the spread of HIV, the virus that causes AIDS, federal officials announced yesterday (December 16th). The extensive program, which is based at the University of Pittsburgh and Magee-Womens Research Institute (MWRI), has completed 13 trials since 2006; 11 more are in progress or will begin within the year; and several new studies will be designed and implemented during the next funding period.

Pitt-led microbicide trials network awarded $70 million over seven years to develop, test HIV prevention products

Date: Dec-18-2013
With funding of $70 million to support its effort into 2021, the Microbicide Trials Network (MTN) will continue to develop and test products that aim to reduce the spread of HIV, the virus that causes AIDS, federal officials announced yesterday (December 16th). The extensive program, which is based at the University of Pittsburgh and Magee-Womens Research Institute (MWRI), has completed 13 trials since 2006; 11 more are in progress or will begin within the year; and several new studies will be designed and implemented during the next funding period.

The Medical Defence Union reports 40% increase in enquiries about social media

Date: Dec-18-2013
The Medical Defence Union (MDU) is reminding doctors to be careful what they post online after several recent articles have highlighted confidential patient information being shared by doctors through social media. The organisation which represents more than half of the UK's doctors has seen an increase of 40% of calls from members in relation to the internet and social media, and warns that doctors must be cautious about the information they chose to share and should consider the GMC's social media guidance when posting online.

Curie-Cancer and Strand launch Curie Image Database

Date: Dec-18-2013
Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activity, and Strand Scientific Intelligence, Inc. (Strand) announce the launch of the Curie Image Database (CID), a breakthrough image analysis and management platform that they developed jointly over the last two years at the Cell and Tissue Imaging Core Facility of the Institut Curie (PICT-IBiSA). CID was created using Strand's award-winning Avadis(R) platform.

Research backs risk-reduction surgery for ovarian cancer

Date: Dec-18-2013
A study by Manchester scientists backs preventative surgery to improve survival for women who are at greater risk of getting ovarian cancer and suggests it appears helpful for women at risk of getting breast cancer because of genetic faults. Women who carry, a fault in one of two high-risk genes known as BRCA1 or BRCA2, have an increased risk of dying from breast and/or ovarian cancer. Many, including high-profile celebrities such as Angelina Jolie, choose to undergo surgery to remove their healthy breasts, ovaries or both before the disease affects them.

The Medical Defence Union reports 40% increase in enquiries about social media

Date: Dec-18-2013
The Medical Defence Union (MDU) is reminding doctors to be careful what they post online after several recent articles have highlighted confidential patient information being shared by doctors through social media. The organisation which represents more than half of the UK's doctors has seen an increase of 40% of calls from members in relation to the internet and social media, and warns that doctors must be cautious about the information they chose to share and should consider the GMC's social media guidance when posting online.

Research backs risk-reduction surgery for ovarian cancer

Date: Dec-18-2013
A study by Manchester scientists backs preventative surgery to improve survival for women who are at greater risk of getting ovarian cancer and suggests it appears helpful for women at risk of getting breast cancer because of genetic faults. Women who carry, a fault in one of two high-risk genes known as BRCA1 or BRCA2, have an increased risk of dying from breast and/or ovarian cancer. Many, including high-profile celebrities such as Angelina Jolie, choose to undergo surgery to remove their healthy breasts, ovaries or both before the disease affects them.